1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

Books

Available from ClinLab Navigator: Essentials of Transfusion Medicine, a convenient and comp...

Books
  • Books

    Books

  • Brand NEW APP - Lab Test Navigator: 800+ Lab Tests for iPhone

    Brand NEW APP - Lab Test Navigator: 800+ Lab Tests for iPhone

  • Brand NEW App - Lab Test Navigator: 800+ Lab Tests for iPad

    Brand NEW App - Lab Test Navigator: 800+ Lab Tests for iPad

Previous
Next

ALK Gene Mutation

Approximately 3 to 5% of non-small cell lung carcinomas (NSCLC) have a rearrangement of the ALK (Anaplastic Lymphoma Kinase) gene, resulting in fusion between ALK and another gene, ALK activation, impaired apoptosis, and abnormal cell proliferation. Tumors expressing ALK fusions are likely to respond to ALK kinase inhibitor drugs such as XALKORI® (crizotinib).

The National Comprehensive Cancer Network (NCCN) guidelines recommend ALK testing for patients with recurrent or metastatic NSCLC with histological subtypes of adenocarcinoma, large cell carcinoma, or NSCLC NOS (not otherwise specified), and for squamous cell carcinoma in never-smokers or when biopsy specimens are small.

FISH is preferred over molecular testing for ALK testing because it detects all known gene rearrangements. The ALK gene has more than 20 known rearrangement partner genes. The most common EML4-ALK fusion has at least 15 variants. Vysis ALK Break Apart FISH Probe Kit is an FDA approved companion diagnostic tests to identify patients for this therapy

In addition to the proven role it plays in select lung cancers, ALK has been found to have a pathogenic role in many cancers including diffuse large B-cell lymphoma, inflammatory myofibroblastic tumor, esophageal squamous cell carcinoma, colorectal cancer and breast cancer. It is estimated that more than 250,000 new cancer diagnoses in the United States each year can be linked to ALK mutations and fusions.

Updated Articles

Fecal Occult Blood…

Colorectal cancer is the only major cancer that affects men and women almost equally. It is rare in persons under age 40, but the incidence begins to rise substantially after age 50. About 6% of people develop colorectal cancer by 80 years of age…

New Articles

LRP4 Antibodies

Lipoprotein receptor-related protein-4 (LRP4) is a member of a family of membrane proteins with key roles in neuronal and synaptic development. LRP4 protein activates MuSK kinase activity and promotes the clustering of AChR and their stabilization…

Blog

Foodborne Illnesses…

Foodborne illness remains a substantial public health concern in the United States. FoodNet is a collaboration among CDC, 10 state health departments, the U.S. Department of Agriculture’s Food Safety and Inspection Service, and the Food and Drug…

Stay Informed

Amazon Book

Our Sponsors

Login Form

Lectures

Cases That Kept Me Up At Night: Case #1

Case #1 is an overview of transfusion reactions and a discussion of a neonate with both NAIT and Rh HDN.

View More Lectures

Mobile Applications

iPad mini Horz Vert 300w

Get it for: iPhoneiPad

ClinLab Navigator Information

McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
© 2015 ClinLab Navigator, LLC.